ALBIS Co.,Ltd.
Notice Regarding the Results of the Tender Offer by Life Corporation for the Company’s Shares and Changes in Parent Company, Major Shareholders and the Largest Major Shareholder
As a result of the tender offer, Life Corporation has decided to acquire ALBIS Co.,Ltd. shares; the total number of tendered shares, 6,045,556 shares, exceeded the purchase lower limit and the offer was successful. The settlement start date is 2026-11-17. Consequently, ALBIS will become a consolidated subsidiary of Life Corporation and proceed with delisting procedures. There will be changes among major shareholders and their affiliates, and a squeeze-out procedure is planned.
Key Figures
- Purchase price: 3,780 yen
- Number of shares to be purchased: 6,966,769 shares (maximum)
- Settlement start date: 2026-11-17
AI要約
Completion of the TOB and Purchase Details
The tender offer by Life Corporation for ALBIS Co.,Ltd. shares was successful as the total number of tendered shares exceeded the lower limit of the planned purchases. The offer period ran from 2026-09-09 to 2026-11-10 (40 business days), and the purchase price was 3,780 yen per common share. The maximum number of shares to be purchased was 6,966,769 shares, with a lower limit of 4,171,200 shares. The settlement start date is 2026-11-17. After the TOB is completed, ALBIS will become a consolidated subsidiary of Life Corporation and proceed with delisting procedures.
Next Steps and Impact
Following the successful tender offer, procedures to change the registered holders (including a squeeze-out) are planned. The effective date for changes is scheduled as 2026-11-17 (settlement start date). After delisting, ALBIS shares are expected to cease trading on the Tokyo Stock Exchange Prime Market. The offeror and non-tendering agreed shareholders will promptly disclose subsequent procedures.
ALBIS Co.,Ltd.
Company overview · Stock price · Financial data · All IR
